GRM5 and Huntington disease: The authors suggest that the improvements in motor function and reduction in disease pathology after the pharmacological and genetic blockade of mGlu5 in HD mouse models may be due to a reduction in aberrant mGlu5 -regulated REST/NRSF signaling.